TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder - Wikidata - wikimedia - TriplyDB

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

http://www.wikidata.org/entity/Q35944364

about

Subversion of Host Innate Immunity by Uropathogenic Escherichia coli Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection TLR4-mediated expulsion of bacteria from infected bladder epithelial cells.Bacteria-induced uroplakin signaling mediates bladder response to infection Waging war against uropathogenic Escherichia coli: winning back the urinary tract Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis.Association of Toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults.Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2.QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli.Aberrant community architecture and attenuated persistence of uropathogenic Escherichia coli in the absence of individual IHF subunits.Activation of endogenous anti-inflammatory mediator cyclic AMP attenuates acute pyelonephritis in mice induced by uropathogenic Escherichia coli.Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5 Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells Inducible innate resistance of lung epithelium to infection.Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo.Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.A Murine Model for Escherichia coli Urinary Tract Infection.Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP.Effect of pravastatin and fosinopril on recurrent urinary tract infections.Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Androgens Enhance Male Urinary Tract Infection Severity in a New Model Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Treatment and prevention of urinary tract infection with orally active FimH inhibitors.Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice Origins and virulence mechanisms of uropathogenic Escherichia coli TLR-mediated immune responses in the urinary tract.From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.Enzymatic modification of lipid A by ArnT protects Bordetella bronchiseptica against cationic peptides and is required for transmission.A role for collecting duct epithelial cells in renal antibacterial defences.Genetics of innate immunity and UTI susceptibility.

P2860

Q26770272-D77DFA60-F03A-47F4-9D51-FF6AE6841A56 Q28475353-5C904C44-E002-4421-9E80-BA5FC1D495A9 Q30489926-60897E05-C4CA-4B22-AC79-0F333B0F26D0 Q33438417-7F86B6B8-E72A-47FD-8241-C959D8603BF6 Q33613902-D6B4BB1A-4215-4B8A-9920-83626587C563 Q33730488-4EC43EAD-8964-492A-87E2-EA0CEC8989AA Q33769094-ACA2A351-0E8E-4B44-8B86-97B22CB9330A Q33769613-995D0A9D-2597-46C7-8D9B-1357A8A17323 Q33921100-C8D298ED-4ACD-4910-9445-4F5C55C84F23 Q34077992-A8086258-0EE5-4BA3-8B91-13948D14F95A Q34235966-23A92DE6-8247-4E07-A9BC-BCF885E9E004 Q34469467-40B80802-22EF-4BA0-AA4C-B89250A1F8BC Q35008536-99163B8F-3A44-4537-8A20-73ADD2341959 Q35195313-5EF71281-8BD9-4158-82CB-4CA7F1A84929 Q35197365-C83F662B-874C-4596-869E-82386E73DE40 Q35646813-79C49586-3E15-4080-939A-D5FF96C360CB Q35662142-C6985D04-9D74-43D4-8318-2534A52BE0F3 Q35738930-29513908-3428-4177-BD92-77A5FA319E08 Q35754472-E6CDBB82-8327-4B59-A320-FEB2C55CAF14 Q36079542-3AC0A103-4D31-4868-BAF9-01CA3C403C38 Q36163174-0AB2EE72-87C7-4800-85E2-E0536C2FA62E Q36219597-3C92BF99-C0CE-4A97-A50A-0816D3835FE3 Q36539552-89195EED-483B-42A0-AE38-AEF4D8ED5F7D Q36593651-A63E1788-1D03-4B3F-B58B-DEFE4674CFEF Q36718650-B57BD3CC-1C33-406E-89AA-4F494BD9DBBC Q36845149-999DC084-BA83-4A59-B3B0-D37AA5628138 Q36902491-E054B2C9-82BC-4A5E-BB39-5381907F6539 Q36910650-A0F75C76-E32D-40F1-8DC1-41DA913A547A Q36944667-D8D7D7AA-F5A9-4B8B-8EFB-F75A36D742D2 Q36951570-1036C541-E80C-4DF3-B557-0466DBA11912 Q36961034-D12D1C62-6E59-403F-BFC3-8624B9A41A67 Q36981814-0269F93D-4ADD-422D-A646-64AE53449AC9 Q36998104-F2BC9363-8DA5-472B-AFCD-E851377A49BD Q37074933-FB48C7D8-789B-4AF7-8B2D-1867D37E31C9 Q37230837-BC3B2354-C827-4601-A2C6-88F293A25AC4 Q37256577-7E37F40D-8D0B-492B-89BA-CAA5CA801F1F Q37478977-D4C3CC0D-9353-4EC1-8C3F-DE1DC690764A Q37546452-D29FBBCF-225B-4ABE-BA3E-656C00306B5F Q37880232-D07E86C7-93BB-48E7-B283-668F186AA637 Q37900471-958A3424-49A6-4F4D-B9D5-1BF961915411

P2860

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

http://www.wikidata.org/entity/Q35944364

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

@ast

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

@en

type

label

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

@ast

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

@en

prefLabel

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

@ast

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

@en

P1433

Q35944364-04411447-C6BA-437A-ADED-EA6888B4ECA8

P1476

Q35944364-23A2D619-C58F-4DD9-B4AA-E1E396E13F1E

P2093

Q35944364-4FDF2F4D-1491-4A0B-996A-29A752F7CB52

Q35944364-695C5AF3-8245-4D7C-B9B9-CD0727D7D014

Q35944364-718156B2-AA99-4758-9A53-3C62E208F38C

Q35944364-7570AC0F-61D0-4F4D-8AB1-346552A1C104

Q35944364-95AAF31E-7FCF-463B-BA30-FDF01AE9D514

P2860

Q35944364-012CDE28-F775-4F51-A645-AEDC3620D6D2

Q35944364-0199F605-56A0-472F-93DA-5DA91F851CEC

Q35944364-05BD1EE6-8E3B-4471-9FC0-2CE54B470C2E

Q35944364-0AE925AF-1D55-4009-AF32-338EA1BC9B8F

Q35944364-0D9FEFA2-9521-458B-B74E-715F57F66A55

Q35944364-11BA1340-9544-486F-9E34-7FB7BE5DE7EC

Q35944364-13395702-AB74-4FFE-8A77-DC7889E05615

Q35944364-17F2217F-B25F-4982-9467-AA53ABEC4003

Q35944364-1BAE2CE9-F787-47E7-A168-C3E0A19ECBD0

Q35944364-25C1AE52-EBF6-49F6-876D-3661CF15DE51

P304

Q35944364-B21BEBA1-47FF-4B2E-B45D-93030FA7D432

P31

Q35944364-CC89FD2E-3DA5-4232-9688-61D354D8423E

P356

Q35944364-8285F4AC-5382-4C62-A9E3-2C4DBE7EC4CE

P433

Q35944364-27196CF5-C2BD-4C77-A8BA-0AE981502090

P478

Q35944364-5DF74217-4B4D-4229-822A-2FE8346D2071

P577

Q35944364-675D9294-B760-4C55-8364-997E97AAAB0B

P5875

Q35944364-C7CD939C-6A45-4071-9973-177ED97D7B98

P698

Q35944364-07203837-90D3-498C-AF23-ED2BDCBA645F

P921

Q35944364-F691EEC7-F677-43F5-BAC0-F27331ABA75B

P932

Q35944364-0C8AD671-9EE2-4530-A0F3-BB58E9B0F828

P356

J.CHOM.2007.05.007

P1433

Cell Host & Microbe

P1476

TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder

@en

P2093

Brian L Bishop

http://www.w3.org/2001/XMLSchema#string

Guojie Li

http://www.w3.org/2001/XMLSchema#string

Jeongmin Song

http://www.w3.org/2001/XMLSchema#string

Matthew J Duncan

http://www.w3.org/2001/XMLSchema#string

Soman N Abraham

http://www.w3.org/2001/XMLSchema#string

P2860

Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytes

Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

A brain serine/threonine protein kinase activated by Cdc42 and Rac1

Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells.

Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses

Stretch-regulated exocytosis/endocytosis in bladder umbrella cells.

P304

287-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CHOM.2007.05.007

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6130168

http://www.w3.org/2001/XMLSchema#string

P698

17710226

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

1950120

http://www.w3.org/2001/XMLSchema#string